Healthtech funding in November 2021
European Healthtech startup funding raised during November 2021.
In November 2021, 61 European Healthtech companies closed 61 funding rounds and raised €1.0B in equity funding (excluding debt and grants), up 92.2% versus November 2020. UK led by capital raised, and Ananda Impact Ventures was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.0B
+92.2% vs November 2020 · excl. debt & grants
Funding rounds
61
+19.6% vs November 2020
Companies
61
Top country
UK
Rank among sectors
#4
12.9% of sector funding
Top-10 round share
74.9%
of disclosed capital
Rounds ≥ €100M
3
Top countries
by € raisedHealthtech — top countries by capital, November 2021 — interactive chart.
Data table
| Healthtech — top countries by capital, November 2021 | |
|---|---|
| UK | €387M |
| France | €271M |
| Portugal | €151M |
| Switzerland | €87M |
| Ireland | €49M |
| Sweden | €26M |
| Belgium | €21M |
| Netherlands | €16M |
Stage mix
by € raisedHealthtech — stage mix, November 2021 — interactive chart.
Data table
| Healthtech — stage mix, November 2021 | |
|---|---|
| Series B | €371M |
| Other | €349M |
| Series D+ | €145M |
| Series A | €78M |
| Series C | €50M |
| Seed | €29M |
| Pre-Seed | €11M |
| Crowdfunding | €1.0M |
Exits & M&A
8 Acquisition8 exits · €607M disclosed.
| Current Health | Acquisition | Nov 2021 | €357M |
| Sanifit | Acquisition | Nov 2021 | €205M |
| Infinite Leap | Acquisition | Nov 2021 | €27M |
| Inositec | Acquisition | Nov 2021 | €19M |
Top deals
largest disclosed rounds in November 2021| Company | Stage | Date | Amount |
|---|---|---|---|
| Owkin | Other | Nov 2021 | €159M |
| Sword Health | Series D+ | Nov 2021 | €145M |
| Quell Therapeutics | Series B | Nov 2021 | €138M |
| bit.bio | Series B | Nov 2021 | €89M |
| Lifen | Series C | Nov 2021 | €50M |
| Ieso | Series B | Nov 2021 | €47M |
| GlycoEra | Series A | Nov 2021 | €43M |
| Nuritas | Series B | Nov 2021 | €39M |
| Gyroscope Therapeutics | Other | Nov 2021 | €35M |
| Stilla Technologies | Other | Nov 2021 | €31M |
| Novadip Biosciences | Series B | Nov 2021 | €19M |
| QuantuMDx | Other | Nov 2021 | €18M |
| Closed Loop Medicine | Series A | Nov 2021 | €15M |
| Hilo (Aktiia) | Series A | Nov 2021 | €15M |
| PathoQuest | Series B | Nov 2021 | €15M |
Top investors
most active in November 2021, by deal count- Ananda Impact Ventures2 deals
- Calm Storm Ventures2 deals
- Capital Cell2 deals
- CDP Venture Capital2 deals
- Charles River Laboratories2 deals
- Eurazeo2 deals
- European Investment Bank (EIB)2 deals
- FIRST Fund2 deals
- Kurma Partners2 deals
- Sanofi Ventures2 deals